KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Total Non-Current Liabilities (2016 - 2025)

Amgen (AMGN) has 17 years of Total Non-Current Liabilities data on record, last reported at $78.0 billion in Q2 2025.

  • For Q2 2025, Total Non-Current Liabilities fell 8.15% year-over-year to $78.0 billion; the TTM value through Jun 2025 reached $78.0 billion, down 8.15%, while the annual FY2024 figure was $83.6 billion, 3.05% down from the prior year.
  • Total Non-Current Liabilities reached $78.0 billion in Q2 2025 per AMGN's latest filing, down from $83.6 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $87.9 billion in Q1 2024 and bottomed at $46.2 billion in Q1 2021.
  • Average Total Non-Current Liabilities over 5 years is $69.2 billion, with a median of $78.0 billion recorded in 2025.
  • Peak YoY movement for Total Non-Current Liabilities: fell 8.35% in 2021, then soared 62.35% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $54.1 billion in 2021, then rose by 13.06% to $61.2 billion in 2022, then soared by 40.94% to $86.2 billion in 2023, then fell by 3.05% to $83.6 billion in 2024, then fell by 6.76% to $78.0 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $78.0 billion in Q2 2025, $83.6 billion in Q4 2024, and $81.1 billion in Q3 2024.